Citadel Group — Major Shareholding Notification 2023

Mar 24, 2023

National Storage Mechanism | Additional information

RNS Number : 1886U

Citadel Group

24 March 2023

Ap27

FORM 8.3

IRISH TAKEOVER PANEL

OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER

RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1.             KEY INFORMATION

(a)   Full name of discloser	Citadel Group
(b)   Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.	N/A
(c)   Name of offeror/offeree in relation to whose relevant securities this form relates Use a separate form for each offeror/offeree	HORIZON THERAPEUTICS PLC
(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)	N/A
(e)   Date position held/dealing undertaken For an opening position disclosure, state the latest practicable date prior to the disclosure	23 March 2023
(f)    In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state "N/A"	N/A

2.             INTERESTS AND SHORT POSITIONS

If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.

Ap28

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

(Note 2)

Class of relevant security (Note 3)	Common Stock ISIN IE00BQPVQZ61
	Interests		Short positions
Number	%	Number	%
(1)   Relevant securities owned and/or controlled	4,049,609	1.77	0	0.00
(2)   Cash-settled derivatives	0	0.00	0	0.00
(3)   Stock-settled derivatives (including options) and agreements to purchase/ sell	0	0.00	0	0.00
Total	4,049,609	1.77	0	0.00

All interests and all short positions should be disclosed.

Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.

3.             DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a)           Purchases and sales

Class of relevant security	Purchase/sale	Number of securities	Price per unit (Note 5)
Common	Buy Transaction	10,000	107.8272 USD
Common	Buy Transaction	937	107.8682 USD
Common	Buy Transaction	101	107.9027 USD
Common	Buy Transaction	376	107.9174 USD
Common	Buy Transaction	478	107.9827 USD
Common	Buy Transaction	35	108.1700 USD
Common	DVP Transaction	1,143	107.8000 USD
Common	RVP Transaction	1,143	107.8000 USD
Common	Sell Transaction	126	107.7958 USD
Common	Sell Transaction	626	107.7960 USD
Common	Sell Transaction	248	107.7962 USD
Common	Sell Transaction	1,343	107.8000 USD
Common	Sell Transaction	90	107.8000 USD
Common	Sell Transaction	28	107.8293 USD
Common	Sell Transaction	300	107.8333 USD
Common	Sell Transaction	492	107.8346 USD
Common	Sell Transaction	76	107.8390 USD
Common	Sell Transaction	16	107.8447 USD
Common	Sell Transaction	821	107.8666 USD
Common	Sell Transaction	461	107.8668 USD
Common	Sell Transaction	2,208	107.8672 USD
Common	Sell Transaction	464	107.8722 USD
Common	Sell Transaction	1,193	107.8724 USD
Common	Sell Transaction	243	107.8725 USD
Common	Sell Transaction	50	107.8800 USD
Common	Sell Transaction	188	107.8864 USD
Common	Sell Transaction	344	107.8865 USD
Common	Sell Transaction	906	107.8866 USD
Common	Sell Transaction	328	107.8969 USD
Common	Sell Transaction	1,572	107.8976 USD
Common	Sell Transaction	106	107.9004 USD
Common	Sell Transaction	591	107.9004 USD
Common	Sell Transaction	510	107.9013 USD
Common	Sell Transaction	192	107.9028 USD
Common	Sell Transaction	9,328	107.9029 USD
Common	Sell Transaction	5,234	107.9033 USD
Common	Sell Transaction	24,911	107.9033 USD
Common	Sell Transaction	140	107.9040 USD
Common	Sell Transaction	678	107.9046 USD
Common	Sell Transaction	258	107.9049 USD
Common	Sell Transaction	3,551	107.9088 USD
Common	Sell Transaction	1,338	107.9090 USD
Common	Sell Transaction	747	107.9094 USD
Common	Sell Transaction	707	107.9221 USD
Common	Sell Transaction	11	107.9600 USD
Common	Sell Transaction	219	108.1547 USD
Common	Sell Transaction	987	108.1633 USD
Common	Sell Transaction	349	108.1697 USD

Ap29

(b)           Cash-settled derivative transactions

Class of relevant security	Product description e.g. CFD	Nature of dealing e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position	Number of reference securities (Note 6)	Price per unit (Note 5)

(c)           Stock-settled derivative transactions (including options)

(i)            Writing, selling, purchasing or varying

Class of relevant security	Product description e.g. call option	Writing, purchasing, selling, varying etc.	Number of securities to which option relates (Note 6)	Exercise price per unit	Type e.g. American, European etc.	Expiry date	Option money paid/ received per unit

(ii)           Exercise

Class of relevant security	Product description e.g. call option	Exercising/ exercised against	Number of securities	Exercise price per unit (Note 5)

(d)           Other dealings (including transactions in respect of new securities) (Note 3)

Class of relevant security	Nature of dealing e.g. subscription, conversion, exercise	Details	Price per unit (if applicable) (Note 5)

Ap30

4.             OTHER INFORMATION

(a)           Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer. Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"
None

(b)           Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None

(c)           Attachments

Is a Supplemental Form 8 attached?	NO

Date of disclosure	24 March 2023
Contact name	Paula Sharp
Telephone number	020 7645 9700

Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RETPPUWUWUPWGPC